HIV Self-Testing and Long-Acting Injectables for HIV Treatment and Prevention Among Commercial Minibus Drivers (I-TEST LAIs) in Nigeria

Starting soon · Phase 4

Conditions studied: HIV

In brief

Long-acting injectable antiretroviral therapy (LAI ART) and Pre-Exposure Prophylaxis (LAI PrEP) have the potential to transform HIV treatment and prevention, especially in reaching individuals such as commercial minibus drivers who have minimal or no contact with traditional health facilities. The project proposes to use a culturally appropriate and community-engaged approach to promote the uptake of HIV self-testing, LAI-ART, and LAI-PrEP among commercial minibus drivers in Nigeria by engaging commercial minibus drivers as peer educators/research facilitators.

Key facts

Study ID

NCT07000513

Run by

George Washington University

People needed

400

Starts

2027-02-01

Expected to finish

2029-08-01

Last updated by the study team

2026-05-15

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Male commercial minibus drivers who have worked as a driver for at least 6 months
• 18 years old or older
• Currently and planning on residing in one of the LGAs during the next 12 months
• Owning a mobile phone

You may not qualify if…

• Known HIV positivity
• Not ability to provide informed consent3
• No access to a cell phone

Where it is running

• National Institute of Medical Research — Lagos, Lagos, Nigeria

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.